CD36 antagonist, Nobiletin (NOB) and its derivatives, including 5-Demethylnobiletin (5-DMN) and NOB-metabolites, show an anti-cancer effect by regulation of cell cycle, apoptosis, and inflammation in CRC cell lines [279,280,281]. The gene discussed is CD36; the disease is colorectal carcinoma.